Saudi Arabia Tumor Marker

Saudi Arabia Tumor Marker Market Research Report Forecast: (2022-2027)

By Type (Cancer antigen 19-9, Alpha-fetoprotein, Beta-2-microglobulin (B2M), Cancer antigen 125, Prostate-Specific Antigen, Cancer Antigen 15-3 & and CA 27-29, Thyroid Transcription factor-1, Crcinoem Read more

  • Healthcare
  • Mar 2022
  • 112
  • HC22024

Market Definition

A tumor marker is a substance present in the blood, urine, or tissue of the body & referred to as proteins made by the healthy & cancer cells. Tumor markers, also known as biomarkers, are any physical, cellular, chemical, or molecular change that can be noted or studied. These substances are used principally for understanding the effects of treatment, occurrence, progress, & disease risk by examining any modification in their usual amount.

Market Insights

The Saudi Arabia Tumor Marker Market is projected to grow at a substantial CAGR during the forecast period, i.e., 2022-27. The growth of the market is driven primarily by the growing focus of the Saudi government on enhancing the healthcare infrastructure, coupled with its support through massive investments, initiatives, and norms for the development of tumor markers across the country. 

Report Coverage Details
Study Period Historical Data: 2017-20
Base Year: 2021
Forecast Period: 2022-27
Region Covered North, West, South, East, Central
Key Companies Profiled Fujirebio, Randox, Bio-Rad, Cepheid, Roche, MP Biomedicals, DiaSorin, Leica Biosystems, Biomerieux
Unit Denominations USD Million/Billion

 

Besides, with an accelerating number of cancer patients and individuals seeking personalized medicines, the demand for tumor markers is surging swiftly & generating growth opportunities for the leading players to introduce treatments to the people, which, in turn, would further boost the market over the forecast years. Moreover, several pharmaceutical companies inclining toward research & developments on biomarkers to diagnose & treat cancer are also projected to augment the overall market growth through 2027.

Impact of Covid-19 on the Saudi Arabia Tumor Marker Market

The advent of Covid-19 in 2020 had a decelerating effect on most industries across Saudi Arabia, yet the Tumor Marker Market witnessed minimal impacts. Owing to the severity of the pandemic, the government had to suspend different business operations in the country and impose stringent movement restrictions & lockdowns to curb the spread of this dreadful disease.

Since the pandemic had an exponential pressure on the healthcare sector, the government & healthcare professionals prioritized addressing Covid-19 cases and put a temporary hold on other patients whose conditions were not severe and could sustain on medicines. It, in turn, introduced challenges for the leading players in tumor marker development since public gatherings & institutions were suspended. However, since the healthcare sector & medical requirements of the people were categorized as priorities, the demand for tumor markers remained prevalent amidst the crisis.

  1. Introduction
    1. Product Definition
    2. Research Process
    3. Glossary
    4. Market Segmentation
  2. Executive Summary
  3. Saudi Arabia Healthcare Market Overview
  4. Impact of COVID-19 on Saudi Arabia Tumor Marker Market
  5. Expert Verbatim- Interview Excerpts of industry experts
  6. Saudi Arabia Tumor Marker Market Outlook, 2017-2027F
    1. Market Size & Analysis
      1. Revenues
    2. Market Share & Analysis
      1. By Type
        1. Cancer antigen 19-9
        2. Alpha-fetoprotein
        3. Beta-2-microglobulin (B2M)
        4. Cancer antigen 125
        5. Prostate-Specific Antigen
        6. Cancer Antigen 15-3 & CA 27-29
        7. Thyroid Transcription factor-1
        8. Crcinoembryonic antigen
        9. Others
      2. By Application
        1. Diagnosis
        2. Screening
        3. Determine response to therapy
      3. By Cancer
        1. Ovarian
        2. Leukaemia
        3. Prostate
        4. Thyroid
        5. Breast
        6. Colorectal
        7. Lung
        8. Others (Liver)
      4. By Region
        1. North
        2. West
        3. South
        4. East
        5. Central
      5. By Company
        1. Market Shares, By Revenue
        2. Strategic Factorial Indexing
        3. Competitor Placement in MarkNtel Quadrant
    3. Ovarian Tumor Marker Market Outlook, 2017-2027F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Type
        2. By Application
        3. By Region
    4. Leukaemia Tumor Marker Market Outlook, 2017-2027F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Type
        2. By Application
        3. By Region
    5. Prostate Tumor Marker Market Outlook, 2017-2027F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Type
        2. By Application
        3. By Region
    6. Thyroid Tumor Marker Market Outlook, 2017-2027F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Type
        2. By Application
        3. By Region
    7. Breast Tumor Marker Market Outlook, 2017-2027F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Type
        2. By Application
        3. By Region
    8. Colorectal Tumor Marker Market Outlook, 2017-2027F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Type
        2. By Application
        3. By Region
    9. Lung Tumor Marker Market Outlook, 2017-2027F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Type
        2. By Application
        3. By Region
    10. Market Attractiveness Index
      1. By Type
      2. By Application
      3. By Cancer
      4. By Region
  7. Saudi Arabia Tumor Marker Market Policies, Regulations, Product Standards
  8. Saudi Arabia Tumor Marker Market Trends & Insights
  9. Saudi Arabia Tumor Marker Market Dynamics
    1. Growth Drivers
    2. Challenges
    3. Impact Analysis
  10. Saudi Arabia Tumor Marker Market Hotspots & Opportunities
  11. Saudi Arabia Tumor Marker Market Key Strategic Imperatives for Success & Growth
  12. Saudi Arabia Tumor Marker Market Competition Outlook
    1. Competition Matrix
      1. Product Portfolio
      2. Research & Development
      3. Strategic Alliances
      4. Strategic Initiatives
    2. Company Profiles of top companies (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
      1. Fujirebio
      2. Randox
      3. Bio-Rad
      4. Cepheid
      5. Roche
      6. MP Biomedicals
      7. DiaSorin
      8. Leica Biosystems
      9. Biomerieux
  13. Disclaimer
Saudi Arabia Tumor Marker Market Segmentation
*This field is required